Lewis Hay III
CIK: 0001182705
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 13, 2026ELV
Elevance Health, Inc.
Award(A)Direct563 shares- - May 11, 2026LHX
L3HARRIS TECHNOLOGIES, INC. /DE/
Award(A)Direct661 shares- - May 14, 2025ELV
Elevance Health, Inc.
Award(A)Direct601 shares- - Apr 21, 2025LHX
L3HARRIS TECHNOLOGIES, INC. /DE/
Award(A)Direct887 shares-
1-4 of 4 transactions
About HAY LEWIS III
HAY LEWIS III (SEC CIK 0001182705) files insider reports with the SEC as Director of Elevance Health, Inc. (ELV) and Director of L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX).
Signal8 holds 4 ownership filings by HAY LEWIS III, all Form 4s, filed between Apr 22, 2025 and May 15, 2026. Those filings report 4 transactions, from Apr 21, 2025 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HAY LEWIS III's filings is in MELBOURNE, FL.
Recent filings by HAY LEWIS III
Other insiders filing for Elevance Health, Inc. (ELV)
- Kaye Mark, EVP & CFO
- Wessling Erin M, EVP & Chief Legal Officer
- Craig Ryan R, EVP & Chief HR Officer
- PERU RAMIRO G, Director
- BOUDREAUX GAIL, President and CEO
- Penczek Ronald W, CAO & Controller